ZONTIVITY is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Wraser Pharmaceuticals, Llc. The primary component is Vorapaxar Sulfate.
| Product ID | 66992-208_e946b6c2-23db-0d65-e053-2a95a90acd48 |
| NDC | 66992-208 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ZONTIVITY |
| Generic Name | Vorapaxar |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-09-21 |
| Marketing Category | NDA / |
| Application Number | NDA204886 |
| Labeler Name | WraSer Pharmaceuticals, LLC |
| Substance Name | VORAPAXAR SULFATE |
| Active Ingredient Strength | 2 mg/1 |
| Pharm Classes | Protease-activated Receptor-1 Antagonist [EPC], Protease-activated Receptor-1 Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-09-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 66992-208 | ZONTIVITY | vorapaxar |
| 70347-208 | ZONTIVITY | vorapaxar |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ZONTIVITY 86164928 not registered Dead/Abandoned |
Merck Sharp & Dohme Corp. 2014-01-14 |
![]() ZONTIVITY 85307417 4628973 Live/Registered |
ARALEZ PHARMACEUTICALS TRADING DESIGNATED ACTIVITY COMPANY 2011-04-28 |